6 Einträge gefunden

1. TMPRSS2-ERG Fusions Are Strongly Linked to Young Patient Age in Low-grade Prostate Cancer

   1. Steurer, Stefan
   2. Mayer, Pascale Sophia
   3. Adam, Meike
   4. Krohn, Antje
   5. Koop, Christina
   6. Ospina-Klinck, Daniel
   7. Tehrani, Ali Attarchi

   2014 - Forschungsinformationssystem des UKE
2. Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer

   1. Kluth, Martina
   2. Harasimowicz, Silvia
   3. Burkhardt, Lia
   4. Grupp, Katharina
   5. Krohn, Antje
   6. Prien, Kristina
   7. Gjoni, Jovisa

   2014 - Forschungsinformationssystem des UKE
3. Heterogeneity and chronology of PTEN deletion and ERG fusion in prostate cancer

   1. Krohn, Antje
   2. Freudenthaler, Fabian
   3. Harasimowicz, Silvia
   4. Kluth, Martina
   5. Fuchs, Sarah
   6. Burkhardt, Lia
   7. Stahl, Phillip

   2014 - Forschungsinformationssystem des UKE
4. CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer

   1. Burkhardt, Lia
   2. Fuchs, Sarah
   3. Krohn, Antje
   4. Masser, Sawinee
   5. Mader, Malte
   6. Kluth, Martina
   7. Bachmann, Frederik

   2013 - Forschungsinformationssystem des UKE
5. Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers

   1. Krohn, Antje
   2. Seidel, Annemarie
   3. Burkhardt, Lia
   4. Bachmann, Frederik
   5. Mader, Malte
   6. Grupp, Katharina
   7. Eichenauer, Till

   2013 - Forschungsinformationssystem des UKE
6. Y chromosome losses are exceedingly rare in prostate cancer and unrelated to patient age.

   1. Stahl, Phillip
   2. Kilgué, Adisa
   3. Tennstedt, Pierre
   4. Minner, Sarah Jane Pauline
   5. Krohn, Antje
   6. Simon, Ronald
   7. Krause, Geske

   2012 - Forschungsinformationssystem des UKE